Ann: Bonanza Gold Intersections from New Zone at Marymia, page-31

First 31 Last

Share
Profile

Follow
nippy

11,833 Posts.

752

06/01/20

07:37

Post #: 42238215
Share

Originally posted by kori: ↑

see Samcos we have either sad trolls and/or bitter ex holders of VAN that sold out too early . Simply they can’t admit that they got it wrong...take GT55 for example where I have revealed my calculations for VAN’s future valuation based on the competent persons reports published over the past 2 years...it is my assumptions/calculations and my opinion..the dude states it’s rubbish , which he is entitled to but offers no calculations of his own other than his repetitive “where is the independent report or BFS? “which reveals his own lack of research into and understanding of VAN. Don’t you think the largest government owned Chinese MINING conglomerate NFC and the top 2 VAN holders who are Chinese would have done their own due diligence over the last 6 months before committing to over $70M in finance and equity? Why does NFC have staff currently on site? The Chinese don’t play by GT’s MO of ‘oh let’s just wait for the JORG and the BFS before committing’ They have done their OWN research into the competent persons drilling reports and have acted upon it!!! I have attempted to do my own research as well and have as a consequence i have increased my holdings in VAN.
However my objective of this post is not to disparage the trolls but to offer this ....DO NOT TAKE ANYONES VIEW OR ADVICE ON HC AS GOSPEL INCLUDING MY OWN...DYOR !

Expand

Kori,

The Chinese got heavily involved with CDU - a total basket case in the end so the Chinese can get it wrong.

Just an example = no idea of VAN's real worth.

VAN Price at posting: 16.5¢ Sentiment: None Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The iron ore comeback: Can it last?

ZNC

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

HAS

Hastings progressing Yangibana to production with lower costs